1Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med, 2007,357:248-294.
2Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or TIAs. Stroke, 2006, 37:577-617.
3The SPARCL Investigators. Stroke prevention by aggressive reduction in cholesterol levels (SPARCLE) investigators. High- dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006,355:549-559.
4Anderson JL, Adam CD, Antman EM, et al. ACC/AHA 2007 guidelines for management of patient with unstable angina/non-ST- elevation myocardial infarction. J Am Coil Cardiol, 2007, 50:e1- e157.
5Diener I-IC, Bogousslavsky J, Brass LM, et al. MATCH investigators, aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischemic attack in high-risk patients ( MATCH ) : randomized, double-blind, placebo-controlled trial. Lancet, 2004, 364 : 331-337.
6Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotie events. N Engl J Med, 2006,354:1706-1717.
7Hankey GJ, Eikelboom JW. Aspirin resistance may be a cause of recurrent ischaemie vascular events in patients taking aspirin. BMJ, 2004,328:477-479.
8Storey RF. Variability of response to antiplatelet therapy. Eur Heart J Suppl, 2008,10 Suppl A:A21-A27.
9The European Stroke Organisation (ESO) executive committee and the ESO writing committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis, 2008,25:457-507.
10Diener HCI Modified-release dipyridamole combined with aspirin for secondary stroke prevention. Aging Health ,2005,1 : 19-26.
